121 related articles for article (PubMed ID: 32748150)
1. ASO Author Reflections: Adjuvant Chemoradiation for Patients with Resected Biliary Tract Cancers.
Dee EC; Freret ME; Wo JY
Ann Surg Oncol; 2020 Dec; 27(13):5173-5174. PubMed ID: 32748150
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Adjuvant Chemotherapy for Resected Biliary Tract Cancers-Does One Size Fit All?
Rhodin KE; Lidsky ME
Ann Surg Oncol; 2023 Aug; 30(8):4822-4823. PubMed ID: 37149546
[No Abstract] [Full Text] [Related]
3. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
Kim H; Heo MH; Kim JY
BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
[TBL] [Abstract][Full Text] [Related]
4. Do Any Subgroups of Resected Biliary Tract Cancers Patients That Benefit the Most from Adjuvant Chemoradiation Therapy?
Ma WJ; Zhou RX
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):934-936. PubMed ID: 32918179
[No Abstract] [Full Text] [Related]
5. Patterns of Failure and Need for Biliary Intervention in Resected Biliary Tract Cancers After Chemoradiation.
Shulman RM; Meyer JE
Ann Surg Oncol; 2020 Dec; 27(13):4867-4869. PubMed ID: 32804323
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Phase II Trial of Adjuvant Chemotherapy with S-1 for Node-Positive Biliary Tract Cancer (N-SOG 09).
Ebata T; Mizuno T
Ann Surg Oncol; 2020 Jul; 27(7):2357-2358. PubMed ID: 32206952
[No Abstract] [Full Text] [Related]
7. Primary and adjuvant radiation therapy in gallbladder and extrahepatic biliary tract carcinoma.
Kopelson G; Gunderson LL
J Clin Gastroenterol; 1983 Feb; 5(1):43-50. PubMed ID: 6841948
[TBL] [Abstract][Full Text] [Related]
8. ASO Author Reflections: The Feasibility of Preoperative FDG-Positive Lymph Nodes of Resectable Biliary Tract Cancers for Postoperative Prognosis.
Kubo M; Kobayashi S
Ann Surg Oncol; 2022 Feb; 29(2):945-946. PubMed ID: 34586520
[No Abstract] [Full Text] [Related]
9. Adjuvant Chemotherapy in Resected Biliary Tract Cancer.
Primrose JN
Ann Surg Oncol; 2020 Jul; 27(7):2127-2129. PubMed ID: 32378086
[No Abstract] [Full Text] [Related]
10. Reevaluating Adjuvant Capecitabine for Resected Biliary Tract Cancer.
Benjamin DJ; Prasad V
Oncologist; 2024 Feb; 29(2):100-101. PubMed ID: 37682029
[TBL] [Abstract][Full Text] [Related]
11. Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor.
Dee EC; Freret ME; Wo JY
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):937-939. PubMed ID: 32910277
[No Abstract] [Full Text] [Related]
12. Radiotherapy.
Sannazzari GL; Vasario E; Ozzello F; Rossi A
Rays; 1989; 14(2):155-61. PubMed ID: 2481866
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Characteristics of Surgery for Biliary Tract Cancer that Should be Considered During the Design of Future Clinical Trials.
Kobayashi S; Ikeda M; Nakachi K; Ueno M; Okusaka T; Todaka A; Satoi S; Tomokuni A; Konishi M; Furuse J
Ann Surg Oncol; 2023 Nov; 30(12):7384-7385. PubMed ID: 37442909
[No Abstract] [Full Text] [Related]
14. Clinicopathological Features of Surgically-resected Biliary Tract Cancer Following Chemo-radiation Therapy.
Kobayashi S; Gotoh K; Takahashi H; Akita H; Marubashi S; Yamada T; Teshima T; Nishiyama K; Yano M; Ohigashi H; Ishikawa O; Sakon M
Anticancer Res; 2016 Jan; 36(1):335-42. PubMed ID: 26722062
[TBL] [Abstract][Full Text] [Related]
15. Multidisciplinary considerations for patients with cancer of the pancreas or biliary tract.
Martin RF; Rossi RL
Surg Clin North Am; 2000 Apr; 80(2):709-28. PubMed ID: 10836013
[TBL] [Abstract][Full Text] [Related]
16. ASO Author Reflections: Adjuvant Chemoradiation in Resected Biliary Cancers-Insights and Implications.
Dominguez DA; Melstrom LG
Ann Surg Oncol; 2024 Mar; ():. PubMed ID: 38472671
[No Abstract] [Full Text] [Related]
17. Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.
Nakachi K; Konishi M; Ikeda M; Shimada K; Okusaka T; Saiura A; Ishii H; Sugiyama M; Furuse J; Sakamoto H; Shimamura T; Ohta T
Int J Clin Oncol; 2018 Oct; 23(5):894-899. PubMed ID: 29705976
[TBL] [Abstract][Full Text] [Related]
18. ASO Author Reflections: Hypoxia-Induced PLOD2 Is a Key Regulator in Epithelial-Mesenchymal Transition and Chemoresistance in Biliary Tract Cancer.
Okumura Y; Eguchi H
Ann Surg Oncol; 2018 Nov; 25(12):3738-3739. PubMed ID: 30167909
[No Abstract] [Full Text] [Related]
19. Improved survival in resected biliary malignancies.
Nakeeb A; Tran KQ; Black MJ; Erickson BA; Ritch PS; Quebbeman EJ; Wilson SD; Demeure MJ; Rilling WS; Dua KS; Pitt HA
Surgery; 2002 Oct; 132(4):555-63; discission 563-4. PubMed ID: 12407338
[TBL] [Abstract][Full Text] [Related]
20. [Chemoradiotherapy for locally recurrence after primary resection of biliary-pancreatic cancer].
Maemura K; Shinchi H; Noma H; Mataki Y; Kurahara H; Maeda S; Natsugoe S; Takao S
Gan To Kagaku Ryoho; 2009 Feb; 36(2):265-8. PubMed ID: 19223743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
